ISRCTN28849775终止1 期
Phase I Trial, Quotient Code: QSC300320 [The full scientific title will be published within 30 months after the end of the trial]
orgine (United Kingdom)0 个研究点目标入组 126 人开始时间: 2022年10月5日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 终止
- 发起方
- 入组人数
- 126
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Healthy human volunteer
排除标准
- •The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.
研究者
相似试验
进行中（未招募）
1 期
Phase I trial, Quotient Code: QSC300720The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.ISRCTN57359805Veradermics Inc16
进行中（未招募）
1 期
Phase I Trial: Quotient Code QSC301361The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.ISRCTN24628458IFM Management, Inc127
进行中（未招募）
1 期
Phase I trial: Quotient code QSC300553The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.ISRCTN10736175Melinta Therapeutics (United States)16
进行中（未招募）
1 期
Phase I trial, Quotient code: QSC301137, Sponsor code: LMNL6511C1001The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.ISRCTN46791858iminal BioSciences (United Kingdom)88
进行中（未招募）
1 期
Phase I trial: Quotient code QSC301152Healthy volunteersISRCTN65070683ovartis (Switzerland)88